This section applies to plasma pastes and labile blood products intended for the preparation of health products. It also applies to labile blood products for direct therapeutic use included on the list referred to in 1° of Article L. 1221-8, and to those which are the subject of a biomedical research protocol prior to their inclusion on the aforementioned list.
The provisions of this section apply to the Armed Forces Blood Transfusion Centre.